- Home
- BELFB vs MDXG Comparison
BELFB vs MDXG Comparison
Compare BELFB & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BELFB
- MDXG
- Stock Information
- Founded
- BELFB 1949
- MDXG 2006
- Country
- BELFB United States
- MDXG United States
- Employees
- BELFB N/A
- MDXG N/A
- Industry
- BELFB
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- BELFB
- MDXG Health Care
- Exchange
- BELFB Nasdaq
- MDXG Nasdaq
- Market Cap
- BELFB 865.9M
- MDXG 1.0B
- IPO Year
- BELFB N/A
- MDXG N/A
- Fundamental
- Price
- BELFB $72.70
- MDXG $7.05
- Analyst Decision
- BELFB Strong Buy
- MDXG Strong Buy
- Analyst Count
- BELFB 3
- MDXG 3
- Target Price
- BELFB $98.33
- MDXG $12.00
- AVG Volume (30 Days)
- BELFB 89.4K
- MDXG 812.0K
- Earning Date
- BELFB 04-24-2025
- MDXG 04-30-2025
- Dividend Yield
- BELFB 0.39%
- MDXG N/A
- EPS Growth
- BELFB N/A
- MDXG N/A
- EPS
- BELFB 3.42
- MDXG 0.27
- Revenue
- BELFB $558,940,000.00
- MDXG $352,375,000.00
- Revenue This Year
- BELFB $22.35
- MDXG $9.23
- Revenue Next Year
- BELFB $5.36
- MDXG $11.49
- P/E Ratio
- BELFB $21.16
- MDXG $26.15
- Revenue Growth
- BELFB N/A
- MDXG 5.34
- 52 Week Low
- BELFB $58.00
- MDXG $5.47
- 52 Week High
- BELFB $92.61
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- BELFB 55.05
- MDXG 51.34
- Support Level
- BELFB $67.50
- MDXG $6.53
- Resistance Level
- BELFB $74.29
- MDXG $7.07
- Average True Range (ATR)
- BELFB 3.25
- MDXG 0.33
- MACD
- BELFB 0.87
- MDXG 0.10
- Stochastic Oscillator
- BELFB 84.55
- MDXG 68.03
About BELFB Bel Fuse Inc. Class B
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.